Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / Gilead Sciences, Inc.
Form 13F · Q2 2026

Gilead Sciences, Inc.

CIK 882095Filed 2026-08-0313F-HR View the filing on EDGAR ↗
$1.6B
Reported book value
5
Positions
7
Quarters on record
Top 50
Positions

Gilead Sciences, Inc. — holdings

Top 5 positions of 5, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1RCUS Arcus Biosciences Inc31.4M+0.0%$969M58.8%
2LKFT Lakefront Biotherapeutics16.7M+0.0%$500M30.3%
3ASMB Assembly Biosciences Inc5.0M+10.5%$137M8.3%
4KYTX Kyverna Therapeutics Inc4.1M+0.0%$37M2.2%
5XLO Xilio Therapeutics Inc.650,389+0.0%$6M0.4%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.